Skip to main content

Table 5 Comparison of three MR Relaxometry technology parameters of sacroiliac joint among subgroups of the Activity group

From: Monitoring the efficacy of tumor necrosis factor alpha antagonists in the treatment of Ankylosing spondylarthritis: a pilot study based on MR relaxometry technique

 

Moderate group

High disease activity group

Very high disease activity group

T1-mapping(ms) sacral

453.05(45.54, 05.87)

511.20(327.19, 013.62)

734.93(558.17, 221.37)

T2-mapping(ms) sacral

105.58(91.67, 17.26)

106.28(91.08, 18.50)

112.10(88.43, 37.87)

T2*-mapping(ms) sacral

8.00(6.26, 0.97)

8.15(6.53, 1.07)

8.53(6.67, 1.43)

T1-mapping(ms) iliac

365.23(330.36, 84.84)

616.15(373.00, 47.78)

848.83(528.93, 134.23)

T2-mapping(ms) iliac

103.90(88.82, 09.44)

100.20(87.77, 10.34)

105.97(90.77, 18.87)

T2*-mapping(ms) iliac

6.78(6.29, 0.72)

7.83(6.67, 0.61)

8.77(7.17, 0.83)